FastWave issued seventh utility patent for its IVL portfolio

69
FastWave
FastWave Medical IVL system

FastWave Medical has announced the issuance of its seventh utility patent by the US Patent and Trademark Office (USPTO). This patent covers FastWave’s laser intravascular lithotripsy (IVL) technology, specifically engineered to address calcified arteries.

“Calcified arteries remain one of the most difficult conditions to treat in our field,” said interventional cardiologist Amir Kaki (Henry Ford St. John’s Hospital, Detroit, USA). “FastWave’s laser IVL platform is a compelling advancement that should provide a more precise, efficient, and predictable way to manage complex arterial disease.”

“This milestone reflects the incredible talent of our entire team and our dedication to equipping physicians with cutting-edge tools for their most challenging cases,” said Scott Nelson, co-founder and chief executive officer of FastWave Medical.

FastWave’s chief operations officer Tristan Tieso added: “Our laser IVL technology continues to push the boundaries of what’s possible in treating calcified arteries, getting us closer to our primary goal of helping interventionalists ensure the best care for their patients.”

 


LEAVE A REPLY

Please enter your comment!
Please enter your name here